{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Fremont",
      "address_1": "49026 Milmont Dr",
      "reason_for_recall": "Product was distributed without 510(k) approval.",
      "address_2": "",
      "product_quantity": "4 kits",
      "code_info": "Catalog number RD471-60K:  Lot numbers: RD4710111, Exp Jan 2012;  RD4710411, Exp. Apr 2012;  RD4711013, Exp Oct 2014.",
      "center_classification_date": "20140724",
      "distribution_pattern": "Brazil and Ecuador. No US distribution",
      "state": "CA",
      "product_description": "InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use.",
      "report_date": "20140730",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Biogenex Laboratories, Inc.",
      "recall_number": "Z-2113-2014",
      "initial_firm_notification": "Other",
      "product_type": "Devices",
      "event_id": "68709",
      "termination_date": "20140724",
      "more_code_info": "",
      "recall_initiation_date": "20140701",
      "postal_code": "94538-7301",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}